Journals / Kulak Burun Boğaz ve Baş Boyun Cerrahisi / 2020 / Cilt: 28 - Sayı: 3

Evaluation of Coroid Thickness of Patients with Nazal Polype

Nazal Polipi Olan Hastaların Koroid Kalınlığının Değerlendirilmesi

Pages
216–221
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In our study, no significant difference was found in the comparison of choroidal thickness measurement of patients with nasal polyp and healthy volunteers.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Comparison of choroid thicknesses of patients with nasal polyp with control group of healthy individuals.
📊
Key Findings & Data:Material and Methods: A total of 65 patients, 32 patients with nasal polyp and 33 healthy individuals, were included in the study.
💡
Conclusion & Impact:Conclusion: In our study, no significant difference was found in the comparison of choroidal thickness measurement of patients with nasal polyp and healthy volunteers.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Comparison of choroid thicknesses of patients with nasal polyp with control group of healthy individuals. Material and Methods: A total of 65 patients, 32 patients with nasal polyp and 33 healthy individuals, were included in the study. Choroidal thickness was measured with Spectralis® OCT (software version 5.3, Heidelberg Engineering, Heidelberg, Germany) without dilating the pupil. Measurements were taken from the subfovea and the nasal and temporal points at a distance of 1.500 μm from the fovea central. Results: There was no difference between the 2 groups in terms of age and gender (Group 1: p=0.613 and Group 2: p=0.342). The mean subfoveal choroid thickness was 322.31±75.89 in patients with nasal polyp, while it was 397.15±78.70 in the control group. No statistically significant difference was found (p=0.194). Conclusion: In our study, no significant difference was found in the comparison of choroidal thickness measurement of patients with nasal polyp and healthy volunteers.

Özet

Amaç: Nazal polipi olan hastaların koroid kalınlıklarının sağlıklı bireylerden oluşan kontrol grubuyla karşılaştırılması. Gereç ve Yöntemler: Çalışmaya, nazal polipi olan 32 hasta ve 33 sağlıklı birey olmak üzere toplam 65 hasta dâhil edildi. Koroid kalınlığı pupil dilate edilmeden Spectralis® OCT (software version 5.3, Heidelberg Engineering, Heidelberg, Almanya) cihazı ile ölçüldü. Fovea santralinden ve fovea santraline 1.500 μm mesafedeki nazal ile temporal noktalardan ölçümler alındı. Bulgular: Ortalama yaş ve cinsiyet açısından 2 grup arasında fark bulunmadı (Grup 1: p=0,613 ve Grup 2: p=0,324). Ortalama subfoveal koroid kalınlığı nazal polipi olan hastalarda 322,31±75,89 iken kontrol grubunda 397,15±78,70 idi. İstatistiksel olarak anlamlı bir fark bulunamadı (p=0,194). Sonuç: Çalışmamızda, nazal polipi olan hastalarla sağlıklı gönüllü hastaların koroid kalınlık ölçümünün karşılaştırmasında anlamlı fark bulunamamıştır.

🔖

Cite This Article

ELİBOL, E. S., DOĞAN, R., ELBAY, A., CIRIK, A. A., AYKUT, V., YENİGÜN, A. (2020). Evaluation of Coroid Thickness of Patients with Nazal Polype. Kulak Burun Boğaz ve Baş Boyun Cerrahisi, Cilt: 28 - Sayı: 3, 216–221. https://ajindex.com/articles/346540

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Nicholson B, Noble J, Forooghian F, Meyerle C. Central serous chorioretinopathy: update on pathophysiology and treatment. Surv Ophthalmol. 2013
  2. 58(2):103-26.[Crossref] [PubMed] [PMC] 2. Bouzas EA, Karadimas P, Pournaras CJ. Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol. 2002
  3. 47(5):431-48.[Crossref] [PubMed] 3. Mirza RG, Gill M. Central serous chorioretinopathy associated with unusual routes of steroid administration. Retin Cases Brief Rep. 2009
  4. 3(1):99-101.[Crossref] [PubMed] 4. Yannuzzi LA. Central serous chorioretinopathy: a personal perspective. American J Ophthalmol. 2010149(3):361-3.[Crossref] [PubMed] 5. Imamura Y, Fujiwara T, Margolis R, Spaide RF. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina. 2009
  5. 29(10):1469- 73.[Crossref] [PubMed] 6. Yenigun A, Elbay A, Dogan R, Ozturan O, Ozdemir MH. The effect of allergic rhinitis with positive skin prick test on choroidal thickness. Eur Arch Otorhinolaryngol. 2017
  6. 274(6):2477- 81.[Crossref] [PubMed] 7. Ulaş F, Doğan Ü, Çelik F, Soydan A, Çelebi S, Dikbaş OJJoR-V. Evaluation of retinal, retinal nerve fiber layer and choroidal thicknesses in diabetic patients without diabetic retinopathy. Journal of Retina Vitreus. 2015
  7. 23(4):331-5. 8. Ulaş F, Dogan Ü, Dikbas O, Celebi S, Keles A. Investigation of the choroidal thickness in patients with hypothyroidism. Indian J Ophthalmol. 2015
  8. 63(3):244-9.[Crossref] [PubMed] [PMC] 9. Akay F, Genç H, Kumbul YÇ. Effect of the inflammatory bowel diseases on choroidal and macular thickness. Med J SDU. 2018
  9. 25(3):317-21. 10. Elbay A, Yenigün A, Özdemir H, Çalım ÖF, Ekinci C, Çetinkaya R, et al. [Does corticosteroid nasal spray use play a role in development of central serous chorioretinopathy?]. Anatol Clin. 2017
  10. 22(3):163-8.[Crossref] 11. Katırcıoğlu OS. [Nasal polyposis: decription and history, prevalence, ethiopatho-genesis, clinical, diagnosis and physical exam, treatment]. Turkiye Klinikleri J Surg Med Sci. 2006
  11. 2(23):8-15. 12. Spaide RF, Koizumi H, Pozzoni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol. 2008
  12. 146(4):496-500.[Crossref] [PubMed] 13. Margolis R, Spaide RF. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol. 2009
  13. 147(5):811-5.[Crossref] [PubMed] 14. Manjunath V, Taha M, Fujimoto JG, Duker JS. Choroidal thickness in normal eyes measured using Cirrus HD op